2022 - Research.com Best Scientist Award
2022 - Research.com Medicine in Belgium Leader Award
2019 - Member of Academia Europaea
2017 - Royal Netherlands Academy of Arts and Sciences
2010 - Member of the European Academy of Sciences
2010 - German National Academy of Sciences Leopoldina - Deutsche Akademie der Naturforscher Leopoldina – Nationale Akademie der Wissenschaften Anatomy and Anthropology
2006 - Sheila Essey Award for ALS Research, American Academy of Neurology
Member of the European Molecular Biology Organization (EMBO)
His primary areas of investigation include Angiogenesis, Immunology, Cancer research, Internal medicine and Endocrinology. Peter Carmeliet interconnects Vascular endothelial growth factor A, Vascular endothelial growth factor, Cancer and Cell biology in the investigation of issues within Angiogenesis. The study incorporates disciplines such as Plasminogen activator, Placental growth factor, Vasculogenesis and Tissue factor in addition to Immunology.
His research in Cancer research intersects with topics in Cancer cell, Downregulation and upregulation, Metastasis, Endothelium and In vivo. His Endocrinology research integrates issues from Calcitriol receptor and Receptor. In his work, Disease is strongly intertwined with Bioinformatics, which is a subfield of Neovascularization.
His primary scientific interests are in Internal medicine, Angiogenesis, Cell biology, Endocrinology and Cancer research. His studies deal with areas such as Vascular endothelial growth factor A, Vascular endothelial growth factor, Endothelial stem cell and Pathology as well as Angiogenesis. His Cell biology study combines topics in areas such as Glycolysis, Metabolism and Endothelium.
His Endocrinology study frequently involves adjacent topics like Receptor. His biological study spans a wide range of topics, including Cancer, Metastasis, Plasminogen activator inhibitor-1, Downregulation and upregulation and Immunology. His Immunology research is multidisciplinary, incorporating elements of Plasmin and In vivo.
Cell biology, Angiogenesis, Endothelial stem cell, Cancer research and Internal medicine are his primary areas of study. Peter Carmeliet interconnects Glycolysis, Glutamine, Phenotype and Transcription factor in the investigation of issues within Cell biology. His primary area of study in Angiogenesis is in the field of Neovascularization.
His research on Cancer research also deals with topics like
Peter Carmeliet focuses on Cell biology, Angiogenesis, Endothelial stem cell, Cancer research and Metabolism. His Cell biology research incorporates elements of Phenotype, Oxidative stress and Glutamine. His Angiogenesis research is mostly focused on the topic Neovascularization.
The various areas that Peter Carmeliet examines in his Endothelial stem cell study include Reactive oxygen species, Vascular endothelial growth factor, Growth factor, Cell type and Lumen. His study in Cancer research is interdisciplinary in nature, drawing from both Cancer cell, Cancer, Disease, Metabolic pathway and Endothelium. He is investigating Beta oxidation as part of his Endocrinology and Internal medicine and Beta oxidation study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Angiogenesis in cancer and other diseases
Peter Carmeliet;Rakesh K. Jain.
Mechanisms of angiogenesis and arteriogenesis.
Nature Medicine (2000)
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Peter Carmeliet;Valérie Ferreira;Georg Breier;Saskia Pollefeyt.
Angiogenesis in health and disease.
Nature Medicine (2003)
Molecular mechanisms and clinical applications of angiogenesis
Peter Carmeliet;Rakesh K. Jain.
Angiogenesis in life, disease and medicine
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.
Peter Carmeliet;Yuval Dor;Jean-Marc Herbert;Dai Fukumura.
Basic and Therapeutic Aspects of Angiogenesis
Michael Potente;Holger Gerhardt;Holger Gerhardt;Peter Carmeliet.
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
Peter Carmeliet;Lieve Moons;Aernout Luttun;Valeria Vincenti.
Nature Medicine (2001)
Hypoxia and Inflammation
Holger K Eltzschig;Peter Carmeliet.
The New England Journal of Medicine (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: